Previously undisclosed figures show that a single large pharmaceutical company has received a £3.4 billion tax cut - including £486 million in 2024 alone - from a little-scrutinised tax incentive supposed to stimulate UK innovation, jobs and manufacturing, even though that company has cut UK...
